Benzinga | Nov 13, 2020 09:10AM EST

Qualigen Therapeutics Yesterday Reported Q2 EPS $(0.41), Sales $837.71K

Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.41) per share. The company reported $837.71 thousand in sales this quarter.